CHESS: Human and Computer Mentors for Prostate Cancer Patients
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
The aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL). * CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL * CHESS +Cancer Information Mentor will have the largest impact on QOL (initially and late in treatment) and will be significantly better than either CHESS or Cancer Information Mentor alone. 2. To measure potential intervening or mediating processes, so that we can determine how CHESS and the Cancer Information Mentor produce associated QOL benefits. 3. To conduct exploratory use analyses examining which types of CHESS content, sequential patterns of content use, or other characteristics of use behavior are associated with greater pretest-posttest improvements in QOL. 4. To conduct a secondary analysis exploring whether men whose partners have actively used CHESS do better than those whose partners did not use CHESS.
Key facts
- Study ID
- NCT00516256
- Run by
- M.D. Anderson Cancer Center
- People needed
- 209
- Starts
- 2007-07-03
- Expected to finish
- 2018-05-11
- Last updated by the study team
- 2018-10-24
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Being within 9 weeks of a primary diagnosis of Stage 1 or Stage 2 prostate cancer
- Being 18 years of age or older
- Being able to read and write English at the 6th grade level (as shown by an ability to understand the informed consent)
You may not qualify if…
- Being under 18 years of age.
Where it is running
- Hartford Hospital — Hartford, Connecticut, United States
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.